Search

PROCEPT BioRobotics Corp

Slēgts

SektorsVeselības aprūpe

20.28 2.68

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

20.28

Max

21.21

Galvenie mērījumi

By Trading Economics

Ienākumi

-1.8M

-32M

Pārdošana

6.7M

83M

EPS

-0.56

Peļņas marža

-38.058

Darbinieki

888

EBITDA

-7.3M

-29M

Rekomendācijas

By TipRanks

Rekomendācijas

Neitrāls

Prognoze 12 mēnešiem

+13.33% upside

Dividendes

By Acuity

Nākamie ieņēmumi

2026. g. 3. nov.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-325M

1B

Iepriekšējā atvēršanas cena

17.6

Iepriekšējā slēgšanas cena

20.28

Ziņu noskaņojums

By Acuity

50%

50%

116 / 340 Rangs Healthcare

PROCEPT BioRobotics Corp Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 7. aug. 20:02 UTC

News

Procept Biorobotics shares are higher as analysts adjust ratings; Wells Fargo sets target at $19.00, while UBS downgrades to "neutral" with a $20.00 target.

2026. g. 6. aug. 20:03 UTC

Procept Biorobotics shares are higher Thursday, recovering from an earlier decline. The stock closed above its 20-day moving average amid broader market dynamics.

2026. g. 5. aug. 19:52 UTC

News

Procept Biorobotics shares are higher as TD Cowen maintains a Buy rating and Piper Sandler reiterates its Overweight rating amid increased investor engagement.

2026. g. 4. aug. 23:02 UTC

News

Procept Biorobotics reported a second-quarter loss of $26.9 million and shares are trading lower in after-market hours following the earnings report.

2026. g. 3. aug. 20:03 UTC

News

Procept Biorobotics shares decline amid a securities class action lawsuit alleging financial misrepresentation through inflated sales and excess inventory.

2026. g. 31. jūl. 20:02 UTC

News

Procept Biorobotics shares are rising today, even after UBS downgraded its rating to neutral with a $20 price target.

2026. g. 30. jūl. 19:58 UTC

Procept Biorobotics Corp is rising during Thursday's session, driven by a broader market rally and recovery in technology shares. No specific company news was identified.

2026. g. 29. jūl. 16:26 UTC

Procept Biorobotics Corp shares are higher Wednesday, recovering from earlier losses amid broader market volatility ahead of the Federal Reserve's interest rate decision.

2026. g. 28. jūl. 19:26 UTC

Procept Biorobotics Corp shares are trading higher, reflecting a cumulative gain since Monday, despite negative sentiment from declines in Asian markets.

2026. g. 27. jūl. 17:02 UTC

News

Procept Biorobotics reported Q1 revenue of $83.1 million, a 20% increase. Shares are trading higher, recovering from recent declines since Friday's close.

2026. g. 22. jūl. 19:41 UTC

Procept Biorobotics Corp shares are lower today, diverging from recent gains. Broader market concerns include rising crude oil prices and inflationary pressures.

2026. g. 21. jūl. 16:01 UTC

Procept Biorobotics Corp is declining during Tuesday's session, breaking a trend of higher daily closes. No specific news was identified for the move.

2026. g. 20. jūl. 19:56 UTC

Procept Biorobotics Corp shares are higher today, despite earlier volatility and no specific news. Broader market performance remains mixed amid geopolitical tensions.

Salīdzinājums

Cenas izmaiņa

PROCEPT BioRobotics Corp Prognoze

Cenas mērķis

By TipRanks

13.33% augšup

Prognoze 12 mēnešiem

Vidējais 23.13 USD  13.33%

Augstākais 29 USD

Zemākais 19 USD

Pamatojoties uz 11 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi PROCEPT BioRobotics Corp — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Neitrāls

11 ratings

3

Pirkt

7

Turēt

1

Pārdot

Noskaņojums

By Acuity

116 / 340 Rangs Veselības aprūpe

Ziņu noskaņojums

Neutral

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par PROCEPT BioRobotics Corp

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
help-icon Live chat